Carcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals

Carcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals:



'via Blog this'

Carcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals

Carcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals:



'via Blog this'

CDRI planning to launch Phase-1 trials on 2 candidate drugs to fight malaria, diabetes « New Drug Approvals

CDRI planning to launch Phase-1 trials on 2 candidate drugs to fight malaria, diabetes « New Drug Approvals:



'via Blog this'

Elbasvir, MK 8742 ……….Anti-Hepatitis C Virus Drug in phase 2 « New Drug Approvals

Elbasvir, MK 8742 ……….Anti-Hepatitis C Virus Drug in phase 2 « New Drug Approvals:



'via Blog this'

Ambit Biosciences announces Phase 3 trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation. « New Drug Approvals

Ambit Biosciences announces Phase 3 trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation. « New Drug Approvals: "dIn"



'via Blog this'

NERATINIB, HKI 272, ..Puma presents positive results from phase II trial of its investigational drug PB272 « New Drug Approvals

NERATINIB, HKI 272, ..Puma presents positive results from phase II trial of its investigational drug PB272 « New Drug Approvals:



'via Blog this'

Doravirine, MK-1439 reverse transcriptase inhibitor In Phase 3 for treatment of HIV-1 infection « New Drug Approvals

Doravirine, MK-1439 reverse transcriptase inhibitor In Phase 3 for treatment of HIV-1 infection « New Drug Approvals:



'via Blog this'